Dai Matsuse

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts

Shohei Wakao, Masaaki Kitada, Yasumasa Kuroda et al. · Proceedings of the National Academy of Sciences · 2011 · 299 citations · Full text

Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis

Takuya Matsushita, Takahisa Tateishi, Noriko Isobe et al. · PLoS ONE · 2013 · 213 citations · Full text

Characterization of IgG4 anti‐neurofascin 155 antibody‐positive polyneuropathy

Hidenori Ogata, Ryo Yamasaki, Akio Hiwatashi et al. · Annals of Clinical and Translational Neurology · 2015 · 197 citations · Full text

Anti-neurofascin antibody in patients with combined central and peripheral demyelination

Nobutoshi Kawamura, Ryo Yamasaki, Tomomi Yonekawa et al. · Neurology · 2013 · 183 citations